Drugs / Cannabidiol Oil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05044936 | May 2023 | pelvic muscle wasting | University of New Mexico | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cannabidiol Oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05044936 ↗ |
| Action | Activate | “CBD has been shown to act as an agonist for ionotropic cannabinoid receptors including chemo- and thermosensitive members of the Transient Receptor Potential (TRP) channel superfamily.” NCT05044936 ↗ |
| Route | Topical | “transdermal application of a cream” NCT05044936 ↗ |